Characterization of the latent transforming growth factor ß complex in Bone

Transforming growth factor ß (TGF‐ß) is a 25 kD multifunctional polypeptide with pronounced effects on the proliferation and differentiation of a variety of cells in vitro. TGF‐ß is a potent regulator of the activity of cells with the osteoblast phenotype and of isolated osteoclasts. It is released in increased amounts by bone cultures stimulated to resorb. Organ cultures of neonatal mouse calvaria produce TGF‐ß as an inert large‐molecular‐weight complex that must be dissociated to release biologically active TGF‐ß (5‐8 ng/ml). We have shown recently that stimulated isolated avian osteoclasts release active TGF‐ß from this bone‐derived biologically latent form. In this report we have characterized this bone latent form of TGF‐ß. Only small amounts of active TGF‐ß (<0.5 ng/ml) and no free binding protein are detectable in conditioned medium from bone cultures. Active TGF‐ß can be detected in acid‐treated calvarial conditioned media in which none or only minute amounts could previously be detected. Following incubation at 37°C, this activated TGF‐ß gradually loses activity. Cross‐linking studies using 125I‐labeled TGF‐ß show that this loss of activity is due to TGF‐ß binding to a protein of approximately 300 kD. The TGF‐ß latent complex accumulates in a linear manner and is stable in the presence of serum and the protease trypsin. Increases in temperature and pH extremes dissociate the complex to release active TGF‐ß. Decreases in pH result in an exponential increase in TGF‐ß activity. Significant activation of the latent TGF‐ß was detectable at pH values as high as 4 and 5. Since the osteoclastic microenvironment is acidic during bone resorption, these data suggest that this acidic microenvironment may regulate TGF‐ß activity by releasing active TGF‐ß from its latent complex

[1]  L. Bonewald,et al.  Activation of the bone-derived latent TGF beta complex by isolated osteoclasts. , 1989, Biochemical and biophysical research communications.

[2]  M. Noda Transcriptional regulation of osteocalcin production by transforming growth factor-beta in rat osteoblast-like cells. , 1989, Endocrinology.

[3]  K. Flanders,et al.  Accumulation, localization, and compartmentation of transforming growth factor beta during endochondral bone development , 1988, The Journal of cell biology.

[4]  G. Rodan,et al.  Transcriptional regulation of osteopontin production in rat osteosarcoma cells by type beta transforming growth factor. , 1988, The Journal of biological chemistry.

[5]  M. Sporn,et al.  Nucleotide sequence of chicken transforming growth factor-beta 1 (TGF-β 1) , 1988 .

[6]  G. Roodman,et al.  Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[7]  G. Mundy,et al.  Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures. , 1988, The Journal of clinical investigation.

[8]  Sporn,et al.  Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. , 1988, The Journal of biological chemistry.

[9]  K. Miyazono,et al.  Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization. , 1988, The Journal of biological chemistry.

[10]  H. Moses,et al.  Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium , 1988, The Journal of cell biology.

[11]  I A Silver,et al.  Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. , 1988, Experimental cell research.

[12]  D. Rosen,et al.  Transforming growth factor‐beta modulates the expression of osteoblast and chondroblast phenotypes in vitro , 1988, Journal of cellular physiology.

[13]  S. S. Huang,et al.  Human transforming growth factor beta.alpha 2-macroglobulin complex is a latent form of transforming growth factor beta. , 1988, The Journal of biological chemistry.

[14]  M. O’Connor-McCourt,et al.  Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin. , 1987, The Journal of biological chemistry.

[15]  M. Sporn,et al.  Complementary deoxyribonucleic acid cloning of bovine transforming growth factor-beta 1. , 1987, Molecular endocrinology.

[16]  M. Sporn,et al.  Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro , 1987, The Journal of cell biology.

[17]  G. Mundy,et al.  Effects of Transforming Growth Factor-β on Osteoblastic Osteosarcoma Cells* , 1987 .

[18]  G. Plowman,et al.  Cloning and Sequence Analysis of Simian Transforming Growth Factor-β cDNA , 1987 .

[19]  D. Clemmons,et al.  An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[20]  E. Shooter,et al.  Epidermal growth factor binding protein: identification of a different protein. , 1987, Biochemistry.

[21]  R. Derynck,et al.  Sequence of the porcine transforming growth factor-beta precursor. , 1987, Nucleic acids research.

[22]  G. Mundy,et al.  Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[23]  E. Canalis,et al.  Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. , 1987, The Journal of biological chemistry.

[24]  J. Massagué,et al.  Human platelet-derived transforming growth factor-beta stimulates parameters of bone growth in fetal rat calvariae. , 1986, Endocrinology.

[25]  M. Sporn,et al.  Transforming growth factor-beta: biological function and chemical structure. , 1986, Science.

[26]  A. Rizzino,et al.  Preparation and binding of radioactively labeled porcine transforming growth factor type beta. , 1986, Biochemical and biophysical research communications.

[27]  J. McPherson,et al.  Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta. , 1986, The Journal of biological chemistry.

[28]  D. Lawrence,et al.  Beta-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. , 1986, Biochemical and biophysical research communications.

[29]  E. Chen,et al.  The murine transforming growth factor-beta precursor. , 1986, The Journal of biological chemistry.

[30]  R. Coffey,et al.  Production of transforming growth factors by human colon cancer lines. , 1986, Cancer research.

[31]  D. Lawrence,et al.  Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions , 1985 .

[32]  R. Baron,et al.  Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border , 1985, The Journal of cell biology.

[33]  E. Canalis,et al.  Transforming and nontransforming growth factors are present in medium conditioned by fetal rat calvariae. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Anita B. Roberts,et al.  Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells , 1985, Nature.

[35]  J. Massagué,et al.  Cellular receptors for type beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. , 1985, The Journal of biological chemistry.

[36]  H. Moses,et al.  Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Lawrence,et al.  Normal embryo fibroblasts release transforming growth factors in a latent form , 1984, Journal of cellular physiology.

[38]  M. Sporn,et al.  Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. , 1984, The Journal of biological chemistry.

[39]  S. Handwerger,et al.  Different subcellular storage sites for decidual- and pituitary-derived prolactin: possible explanation for differences in regulation , 1984, Molecular and Cellular Endocrinology.

[40]  Gary L. Smith Somatomedin carrier proteins , 1984, Molecular and Cellular Endocrinology.

[41]  M. Sporn,et al.  Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. , 1983, The Journal of biological chemistry.

[42]  A. Moses,et al.  The growth hormone dependence of a somatomedin-binding protein in human serum. , 1981, The Journal of clinical endocrinology and metabolism.

[43]  G. Smith,et al.  Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Cohen Kl,et al.  The serum half-life of somatomedin activity: evidence for growth hormone dependence. , 1976 .

[45]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[46]  J. Oppenheimer Role of plasma proteins in the binding, distribution and metabolism of the thyroid hormones. , 1968, The New England journal of medicine.

[47]  W. Balfour,et al.  Thyroxine binding by serum proteins , 1960, The Journal of physiology.

[48]  野田 政樹 Transcriptional regulation of osteocalcin production by transfoming growth factor-β in rat osteoblast-like cells , 1992 .

[49]  D. Kamp,et al.  Transforming growth factor-beta (TGF beta) is chemotactic for human monocytes and induces their expression of angiogenic activity. , 1988, Biochemical and biophysical research communications.

[50]  G. Mundy,et al.  Effects of Transforming Growth Factor-/? on Osteoblastic Osteosarcoma Cells* , 1987 .

[51]  G. Mundy,et al.  Effects of transforming growth factor-beta on osteoblastic osteosarcoma cells. , 1987, Endocrinology.

[52]  D. Lawrence,et al.  Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta-TGF under acidic conditions. , 1985, Biochemical and biophysical research communications.

[53]  S. Nissley,et al.  The serum half-life of somatomedin activity: evidence for growth hormone dependence. , 1976, Acta Endocrinologica.